In addition, an anti-cancer effector of the immune cancer environment is the differentiation into CD8+ T cells (cytotoxic T lymphocytes) that kill cancer cells; ROS induces immunogenic cell death by activating ER stress [65]. Here, CD8A is linked to cancer.